RxDoctor Payments Data

Amber Grant, APRN

Family · Newton, KSNPI 1326595042

Payments from drug & device makers

$1,910in general payments, 2019–2025

Across 125 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$231
  • Astellas Pharma US Inc$106
  • Lilly USA, LLC$87
  • Novo Nordisk$82
  • Sumitomo Pharma America, Inc.$38
  • plus $246 from 11 others

What the payments were for

  • Food & beverage$1,89699%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,910 in reported general payments places this provider in the 85th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$46,695
Medicare patients
241
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$29,861
Tresiba Flextouch U-200Insulin Degludec20$25,624
OzempicSemaglutide14$23,242
MounjaroTirzepatide18$19,701
FarxigaDapagliflozin Propanediol18$14,562
XareltoRivaroxaban18$12,053
TradjentaLinagliptin11$8,517
GemtesaVibegron23$5,693
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$1,424
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,192
Carbamazepine28$1,150
Methenamine Hippurate24$966
Colestipol Hcl14$879
Atorvastatin Calcium140$866
Pregabalin35$780

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$231$29,86139 claims
Novo NordiskOzempic$82$23,24214 claims
Lilly USA, LLCMounjaro$87$19,70118 claims
Boehringer IngelheimTradjenta$32$8,51711 claims
Sumitomo Pharma America, Inc.Gemtesa$38$5,69323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,579 family providers in Kansas.

Other family in Newton

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →